1. Regado Biosciences, Inc. Adds Global Pharmaceutical Business Veteran to Board of Directors

    Regado Biosciences, Inc. Adds Global Pharmaceutical Business Veteran to Board of Directors

    BASKING RIDGE, N.J., Nov. 18, 2013 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced the appointment of Pierre Legault, MBA, CA, CPA, to its Board of Directors, where he will serve as Chairman of the audit committee.

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. Throughout my career I have chosen board appointments very carefully, and I see a tremendous opportunity in Regado. As the company continues to drive toward clinical success with REG1, I look forward to offering my expertise and guidance.
  3. Topics Mentioned